Literature DB >> 34120319

Bacteriophage Therapy for Critical and High-Priority Antibiotic-Resistant Bacteria and Phage Cocktail-Antibiotic Formulation Perspective.

Gursneh Kaur1, Ritika Agarwal1, Rakesh Kumar Sharma2.   

Abstract

Phage therapy is revolving to address the issues mainly dealing with antibiotic resistance in the pathogenic bacteria. Among the drug-resistant microbial populations, the bacterial species have been categorized as high-priority or critical-priority bacteria. This review summarizes the efficiency and development in phage therapy used against these drug-resistant bacteria in the past few years mainly belonging to the critical- and high-priority list. Phage therapy is more than just an alternative to antibiotics as it not only kills the target microbial population directly but also leads to the chemical and physical modifications in bacterial cell structures. These phage-mediated modifications in the bacterial cell may make them antibiotic sensitive. Application of phage therapy in antibiotic-resistant foodborne bacteria and possible modulation in gut microbes has also been explored. Further, the phage cocktail antibiotic formulation, containing more than one type of phage with antibiotics, has also been discussed.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antibiotic resistance; Critical priority; High priority; Phage resistance; Phage therapy

Mesh:

Substances:

Year:  2021        PMID: 34120319     DOI: 10.1007/s12560-021-09483-z

Source DB:  PubMed          Journal:  Food Environ Virol        ISSN: 1867-0334            Impact factor:   2.778


  73 in total

1.  Editorial: Bacterial pathogens, antibiotics and antibiotic resistance.

Authors:  Ehud Banin; Diarmaid Hughes; Oscar P Kuipers
Journal:  FEMS Microbiol Rev       Date:  2017-05-01       Impact factor: 16.408

Review 2.  Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy.

Authors:  Aa Haeruman Azam; Yasunori Tanji
Journal:  Appl Microbiol Biotechnol       Date:  2019-01-24       Impact factor: 4.813

Review 3.  Salmonella secretion systems: Differential roles in pathogen-host interactions.

Authors:  Hongxia Bao; Shuang Wang; Jian-Hua Zhao; Shu-Lin Liu
Journal:  Microbiol Res       Date:  2020-09-05       Impact factor: 5.415

4.  Spray-dried anti-Campylobacter bacteriophage CP30A powder suitable for global distribution without cold chain infrastructure.

Authors:  Nicholas B Carrigy; Lu Liang; Hui Wang; Samuel Kariuki; Tobi E Nagel; Ian F Connerton; Reinhard Vehring
Journal:  Int J Pharm       Date:  2019-08-05       Impact factor: 5.875

Review 5.  A bacteriophages journey through the human body.

Authors:  Jeremy J Barr
Journal:  Immunol Rev       Date:  2017-09       Impact factor: 12.988

Review 6.  The Enemy of My Enemy: New Insights Regarding Bacteriophage-Mammalian Cell Interactions.

Authors:  Katie Bodner; Arin L Melkonian; Markus W Covert
Journal:  Trends Microbiol       Date:  2020-11-23       Impact factor: 17.079

7.  Evaluation of Bacteriophage Cocktails Alone and in Combination with Daptomycin against Daptomycin-Nonsusceptible Enterococcus faecium.

Authors:  Taylor Morrisette; Katherine L Lev; Gregory S Canfield; Breck A Duerkop; Razieh Kebriaei; Kyle C Stamper; Dana Holger; Susan M Lehman; Smaranda Willcox; Cesar A Arias; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2021-11-01       Impact factor: 5.938

8.  Isolation and Characterization of phiLLS, a Novel Phage with Potential Biocontrol Agent against Multidrug-Resistant Escherichia coli.

Authors:  Luis Amarillas; Lucia Rubí-Rangel; Cristobal Chaidez; Arturo González-Robles; Luis Lightbourn-Rojas; Josefina León-Félix
Journal:  Front Microbiol       Date:  2017-07-21       Impact factor: 5.640

9.  Identification of Novel Bacteriophages with Therapeutic Potential That Target Enterococcus faecalis.

Authors:  M Al-Zubidi; M Widziolek; E K Court; A F Gains; R E Smith; K Ansbro; A Alrafaie; C Evans; C Murdoch; S Mesnage; C W I Douglas; A Rawlinson; G P Stafford
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

10.  Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.

Authors:  Benjamin K Chan; Mark Sistrom; John E Wertz; Kaitlyn E Kortright; Deepak Narayan; Paul E Turner
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

View more
  4 in total

1.  Characterization of the Bacteriophage BUCT603 and Therapeutic Potential Evaluation Against Drug-Resistant Stenotrophomonas maltophilia in a Mouse Model.

Authors:  Pengjun Han; Wenjing Zhang; Mingfang Pu; Yahao Li; Lihua Song; Xiaoping An; Mengzhe Li; Fei Li; Shuyan Zhang; Huahao Fan; Yigang Tong
Journal:  Front Microbiol       Date:  2022-07-05       Impact factor: 6.064

Review 2.  Bacteriophage therapy in aquaculture: current status and future challenges.

Authors:  Ruyin Liu; Ganghua Han; Zong Li; Shujuan Cun; Bin Hao; Jianping Zhang; Xinchun Liu
Journal:  Folia Microbiol (Praha)       Date:  2022-03-19       Impact factor: 2.629

Review 3.  Microbial Resistance to Antibiotics and Effective Antibiotherapy.

Authors:  Adriana Aurelia Chiș; Luca Liviu Rus; Claudiu Morgovan; Anca Maria Arseniu; Adina Frum; Andreea Loredana Vonica-Țincu; Felicia Gabriela Gligor; Maria Lucia Mureșan; Carmen Maximiliana Dobrea
Journal:  Biomedicines       Date:  2022-05-12

Review 4.  Current Status of Phage Therapy against Infectious Diseases and Potential Application beyond Infectious Diseases.

Authors:  Hao-Ming Xu; Wen-Min Xu; Long Zhang
Journal:  Int J Clin Pract       Date:  2022-10-03       Impact factor: 3.149

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.